T/CMAM Z13-2022 Active Group standards

T/CMAM Z13-2022 The Tibetan medicine guideline for the diagnosis and treatment of cirrhosis and ascites (spleen disease) is as follows: "Qingbasaraxuqi"

T/CMAM Z13-2022 The Tibetan medicine guideline for the diagnosis and treatment of cirrhosis and ascites (spleen disease) is as follows: "Qingbasaraxuqi"

Publish Date: 1970-01-01 Implement Date: 1970-01-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 54.00
Out of stock

Basic Information

Standard Code: T/CMAM Z13-2022
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: -
Publish Date: 1970-01-01
Implement Date: 1970-01-01

Scope

This document specifies the diagnosis, differentiation, and treatment of Qingbashe Syndrome (cirrhosis ascites). This document is applicable to the diagnosis and treatment of Qingbashe Syndrome (cirrhosis ascites).

Development Information

Word Count: 42 Thousand words

Related Standards

Contact Us